Scott T Reents - Net Worth and Insider Trading

Scott T Reents Net Worth

The estimated net worth of Scott T Reents is at least $2 Million dollars as of 2024-04-27. Scott T Reents is the EVP, CHIEF FINANCIAL OFFICER of AbbVie Inc and owns about 15,431 shares of AbbVie Inc (ABBV) stock worth over $2 Million. Details can be seen in Scott T Reents's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott T Reents has not made any transactions after 2024-02-23 and currently still holds the listed stock(s).

Transaction Summary of Scott T Reents

To

Scott T Reents Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott T Reents owns 1 companies in total, including AbbVie Inc (ABBV) .

Click here to see the complete history of Scott T Reents’s form 4 insider trades.

Insider Ownership Summary of Scott T Reents

Ticker Comapny Transaction Date Type of Owner
ABBV AbbVie Inc 2024-02-23 SVP & Chief Financial Officer

Scott T Reents Latest Holdings Summary

Scott T Reents currently owns a total of 1 stock. Scott T Reents owns 15,431 shares of AbbVie Inc (ABBV) as of February 23, 2024, with a value of $2 Million.

Latest Holdings of Scott T Reents

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ABBV AbbVie Inc 2024-02-23 15,431 159.62 2,463,096

Holding Weightings of Scott T Reents


Scott T Reents Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott T Reents has made a total of 2 transactions in AbbVie Inc (ABBV) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in AbbVie Inc is the sale of 14,140 shares on February 23, 2024, which brought Scott T Reents around $3 Million.

Insider Trading History of Scott T Reents

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott T Reents Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott T Reents Ownership Network

Ownership Network List of Scott T Reents

No Data

Ownership Network Relation of Scott T Reents


Scott T Reents Owned Company Details

What does AbbVie Inc do?

Who are the key executives at AbbVie Inc?

Scott T Reents is the SVP & Chief Financial Officer of AbbVie Inc. Other key executives at AbbVie Inc include SVP & Enterprise Innovation Nicholas Donoghoe , SVP & US Commercial Operations Jeffrey Ryan Stewart , and EVP & Chief HR Officer Timothy J. Richmond .

AbbVie Inc (ABBV) Insider Trades Summary

Over the past 18 months, Scott T Reents made 2 insider transaction in AbbVie Inc (ABBV) with a net sale of 30,082. Other recent insider transactions involving AbbVie Inc (ABBV) include a net sale of 58,955 shares made by Elaine K. Sorg , a net sale of 46,663 shares made by Perry C Siatis , and a net sale of 114,860 shares made by Azita Saleki-gerhardt .

In summary, during the past 3 months, insiders sold 459,004 shares of AbbVie Inc (ABBV) in total and bought 0 shares, with a net sale of 459,004 shares. During the past 18 months, 840,580 shares of AbbVie Inc (ABBV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 840,580 shares.

AbbVie Inc (ABBV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AbbVie Inc Insider Transactions

No Available Data

Scott T Reents Mailing Address

Above is the net worth, insider trading, and ownership report for Scott T Reents. You might contact Scott T Reents via mailing address: 1 North Waukegan Road, North Chicago Il 60064.

Discussions on Scott T Reents

No discussions yet.